|
|
|
|
| LEADER |
01958nam a2200361 u 4500 |
| 001 |
EB001840517 |
| 003 |
EBX01000000000000001004506 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
180702 r ||| eng |
| 020 |
|
|
|a 9789283212867
|
| 020 |
|
|
|a 928321286X
|
| 245 |
0 |
0 |
|a Cobalt in hard metals and cobalt sulfate, gallium arsenide, indium phosphide, and vanadium pentoxide
|h Elektronische Ressource
|c IARC Working Group on the Evaluation of Carcinogenic Risks to Humans
|
| 260 |
|
|
|a Lyon, France
|b International Agency for Research on Cancer
|c 2006, 2006
|
| 300 |
|
|
|a xiv, 330 p.
|b ill
|
| 505 |
0 |
|
|a Includes bibliographical references and index
|
| 505 |
0 |
|
|a Metallic cobalt particles (with or without tungsten carbide) -- Introduction to the monographs on gallium arsenide and indium phosphide. Studies of cancer in humans -- Gallium arsenide -- Indium phosphide -- Vanadium pentoxide
|
| 653 |
|
|
|a Carcinogens / toxicity
|
| 653 |
|
|
|a Carcinogenicity Tests
|
| 653 |
|
|
|a Gallium / adverse effects
|
| 653 |
|
|
|a Cobalt / adverse effects
|
| 653 |
|
|
|a Vanadium Compounds / adverse effects
|
| 653 |
|
|
|a Risk Assessment
|
| 653 |
|
|
|a Indium / adverse effects
|
| 710 |
2 |
|
|a IARC Working Group on the Evaluation of Carcinogenic Risks to Humans
|
| 710 |
2 |
|
|a World Health Organization
|
| 710 |
2 |
|
|a International Agency for Research on Cancer
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a IARC monographs on the evaluation of carcinogenic risks to humans
|
| 500 |
|
|
|a "This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 7-14 October 2003.". - At head of title: World Health Organization, International Agency for Research on Cancer
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK321688
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|